Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2040752 | Cell Reports | 2015 | 17 Pages |
•Matrix remodeling induces YAP/TAZ-miR-130/301 early in pulmonary hypertension (PH)•YAP/TAZ-miR-130/301 promotes matrix remodeling via a mechanoactive feedback loop•Such matrix remodeling drives pulmonary vascular activation and cellular crosstalk•Pharmacologic modulation of this circuit ameliorates matrix remodeling and PH
SummaryPulmonary hypertension (PH) is a deadly vascular disease with enigmatic molecular origins. We found that vascular extracellular matrix (ECM) remodeling and stiffening are early and pervasive processes that promote PH. In multiple pulmonary vascular cell types, such ECM stiffening induced the microRNA-130/301 family via activation of the co-transcription factors YAP and TAZ. MicroRNA-130/301 controlled a PPARγ-APOE-LRP8 axis, promoting collagen deposition and LOX-dependent remodeling and further upregulating YAP/TAZ via a mechanoactive feedback loop. In turn, ECM remodeling controlled pulmonary vascular cell crosstalk via such mechanotransduction, modulation of secreted vasoactive effectors, and regulation of associated microRNA pathways. In vivo, pharmacologic inhibition of microRNA-130/301, APOE, or LOX activity ameliorated ECM remodeling and PH. Thus, ECM remodeling, as controlled by the YAP/TAZ-miR-130/301 feedback circuit, is an early PH trigger and offers combinatorial therapeutic targets for this devastating disease.
Graphical AbstractFigure optionsDownload full-size imageDownload as PowerPoint slide